Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. www.who.int › news-room › feature-storiesThe Moderna COVID-19 (mRNA-1273) vaccine: what you need to know

   www.who.int › news-room › feature-stories

   • Αποθηκευμένο αντίγραφο

   18 Αυγ 2022 · The Moderna vaccine after two doses and a first booster dose has been shown to have very high effectiveness against severe disease, hospitalizations and death, and modest effectiveness against symptomatic illness.

2. www.cdc.gov › vaccines › covid-192024–25 Formula Moderna COVID-19 Vaccine - Centers for Disease...

   www.cdc.gov › vaccines › covid-19

   Guidance below summarizes basic storage, preparation, scheduling, administration, and dosage for all 2024–25 Moderna COVID-19 vaccine products.

3. www.cdc.gov › covid › vaccinesStaying Up to Date with COVID-19 Vaccines | COVID-19 | CDC

   www.cdc.gov › covid › vaccines

   • Αποθηκευμένο αντίγραφο

   3 Οκτ 2024 · 1 dose of the 2024–2025 Moderna COVID-19 vaccine OR 1 dose of the 2024–2025 Pfizer-BioNTech COVID-19 vaccine OR 1 dose of the 2024–2025 Novavax vaccine unless you are receiving a COVID-19 vaccine for the very first time.

4. www.fda.gov › media › 167208Moderna COVID-19 Vaccine (2023-2024 Formula) Healthcare Provider...

   www.fda.gov › media › 167208

   Individuals turning from 4 years to 5 years of age during the vaccination series should receive both doses with Moderna COVID-19 Vaccine (2023-2024 Formula). Individuals 5 Years Through 11...

5. www.fda.gov › news-events › press-announcementsFDA Approves and Authorizes Updated mRNA COVID-19 Vaccines to...

   www.fda.gov › news-events › press-announcements

   • Αποθηκευμένο αντίγραφο

   22 Αυγ 2024 · Individuals 6 months through 4 years of age who have previously been vaccinated against COVID-19 are eligible to receive one or two doses of the updated, authorized Moderna or Pfizer-BioNTech...

6. investors.modernatx.com › news › news-detailsModerna Announces Preliminary Booster Data and Updates Strategy...

   investors.modernatx.com › news › news-details

   • Αποθηκευμένο αντίγραφο

   20 Δεκ 2021 · The strategy includes evaluating the prototype vaccine (mRNA-1273) at the authorized booster dose (50 µg) and a higher dose (100 µg), multivalent candidates that incorporate previous VOCs (mRNA-1273.211, mRNA-1273.213) also at 50 µg and 100 µg, and VOC-specific booster candidates (Delta, Omicron).

7. assets.modernatx.com › m › 17d17b09d117ca22FACT SHEET FOR HEALTHCARE PROVIDERS ADMINISTERING VACCINE ... -...

   assets.modernatx.com › m › 17d17b09d117ca22

   doses (Moderna COVID-19 Vaccine or Moderna COVID-19 Vaccine, Bivalent), an additional 0.25 mL dose of Moderna COVID-19 Vaccine, Bivalent (vial with a dark blue cap and a label with a gray border) may be administered at least 1 month following the most recent dose; additional doses of Moderna COVID-19 Vaccine, Bivalent5 may be administered at the